These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 10901457)
1. Use of technetium-99m hexamethylpropylene amine oxime SPET for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet's disease. Pupi A; Sestini S; De Cristofaro MT; Emmi L; Marchione T; Salvati G; Gobbi FL; Massacesi L; Meldolesi U Eur J Nucl Med; 2000 Jun; 27(6):700-6. PubMed ID: 10901457 [TBL] [Abstract][Full Text] [Related]
2. Assessment of cerebral perfusion and cerebrovascular reserve in insulin-dependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide. Jiménez-Bonilla JF; Quirce R; Hernández A; Vallina NK; Guede C; Banzo I; Amado JA; Carril JM Eur J Nucl Med; 2001 Nov; 28(11):1647-55. PubMed ID: 11702106 [TBL] [Abstract][Full Text] [Related]
3. Cerebral perfusion and haemodynamics measured by SPET in symptom-free patients with transient ischaemic attack: clinical implications. Martí-Fàbregas JA; Catafau AM; Marí C; Mendoza G; Sanahuja J; Lleó A; Martí-Vilalta JL Eur J Nucl Med; 2001 Dec; 28(12):1828-35. PubMed ID: 11734922 [TBL] [Abstract][Full Text] [Related]
4. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults. Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088 [TBL] [Abstract][Full Text] [Related]
5. 18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus. Grünwald F; Schomburg A; Badali A; Ruhlmann J; Pavics L; Biersack HJ Eur J Nucl Med; 1995 Sep; 22(9):1073-7. PubMed ID: 7588946 [TBL] [Abstract][Full Text] [Related]
6. Improvement of signal-to-noise ratio using iterative reconstruction in a 99m Tc-ECD split-dose injection protocol. Yokoi T; Shinohara H; Takaki A Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1125-33. PubMed ID: 12768331 [TBL] [Abstract][Full Text] [Related]
7. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection. Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613 [TBL] [Abstract][Full Text] [Related]
9. Acetazolamide-challenged perfusion magnetic resonance imaging for assessment of cerebrovascular reserve capacity in patients with symptomatic middle cerebral artery stenosis: comparison with technetium-99m-hexamethylpropyleneamine oxime single-photon emission computed tomography. Kim HJ; Kim TW; Ryu SY; Yang PS; Kwon MJ; Kim JC; Lee YS; Lee HJ; Yang JH; Kim JK; Chung YA; Oh EY; Lee SB Clin Imaging; 2011; 35(6):413-20. PubMed ID: 22040783 [TBL] [Abstract][Full Text] [Related]
10. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia. Pávics L; Grünwald F; Reichmann K; Horn R; Kitschenberg A; Hartmann A; Menzel C; Schomburg AG; Overbeck B; Csernay L; Biersack HJ Eur J Nucl Med; 1999 Mar; 26(3):239-45. PubMed ID: 10079314 [TBL] [Abstract][Full Text] [Related]
11. A technetium-99m hexamethylpropylene amine oxime brain single-photon emission tomography study in adolescent patients with major depressive disorder. Tutus A; Kibar M; Sofuoglu S; Basturk M; Gönül AS Eur J Nucl Med; 1998 Jun; 25(6):601-6. PubMed ID: 9618574 [TBL] [Abstract][Full Text] [Related]
12. Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography. Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K Eur J Nucl Med; 1996 Jun; 23(6):683-9. PubMed ID: 8662103 [TBL] [Abstract][Full Text] [Related]
13. Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease. Quirce R; Carril JM; Jiménez-Bonilla JF; Amado JA; Gutiérrez-Mendiguchía C; Banzo I; Blanco I; Uriarte I; Montero A Eur J Nucl Med; 1997 Dec; 24(12):1507-13. PubMed ID: 9391186 [TBL] [Abstract][Full Text] [Related]
14. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463 [TBL] [Abstract][Full Text] [Related]
15. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations. Colamussi P; Giganti M; Cittanti C; Dovigo L; Trotta F; Tola MR; Tamarozzi R; Lucignani G; Piffanelli A Eur J Nucl Med; 1995 Jan; 22(1):17-24. PubMed ID: 7698150 [TBL] [Abstract][Full Text] [Related]
16. Acetazolamide induced myocardial ischemia in patients with severe coronary artery disease. Shimotsu Y; Hayashida K; Kume N; Fukuchi K; Nishimura T Ann Nucl Med; 1998 Feb; 12(1):21-7. PubMed ID: 9559958 [TBL] [Abstract][Full Text] [Related]
17. The effect of acetazolamide on regional cerebral blood flow in normal human subjects as measured by single-photon emission computed tomography. Bonte FJ; Devous MD; Reisch JS Invest Radiol; 1988 Aug; 23(8):564-8. PubMed ID: 3262097 [TBL] [Abstract][Full Text] [Related]